OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Childhood Cancer Survivor Who Changed the Law: Pablo Allard’s Advocacy Journey

Christopher Jackson: A Happier Place to Live, A New Opportunity for Medical Oncologists

Breast Care International Calls for Earlier Breast Cancer Detection in Ghana

George Kapetanakis: Greece Begins Building a Patient-Centered National Cancer Action Plan

The Second Act of Thalidomide: How a Withdrawn Drug Gave Rise to a New Class of Myeloma Therapy

Oncology News, Insights, Stories by OncoDaily

Camizestrant
Breast Oncology

Camizestrant and ctDNA-Guided Treatment Switching: A New Paradigm in ESR1-Mutant Advanced Breast Cancer

Nicole Engelbrecht
Voices

Nicole Engelbrecht: UICC's New Ten Year Strategy for 2026-2036 Has Been Published

Giannis Mountzios
Science

Giannis Mountzios: Combination of TCEs and ADCs Holds Promise for Deep and Durable Responses in ES-SCLC

"An Evening for Cure" Gala in Maryland Supports $100M Otumfuo Osei Tutu II Cancer Center in Ghana

Giannis Mountzios: Combination of TCEs and ADCs Holds Promise for Deep and Durable Responses in ES-SCLC

Camizestrant and ctDNA-Guided Treatment Switching: A New Paradigm in ESR1-Mutant Advanced Breast Cancer

OncoDaily Partners with World Radiotherapy Awareness Day to Champion Access, Awareness and Better Cancer Care

Nicole Engelbrecht: UICC's New Ten Year Strategy for 2026-2036 Has Been Published

Bob Li Highlights a Major Step Toward More Equitable Cancer Trials

Busy Philipps Reveals Oligodendroglioma Diagnosis: Symptoms, Treatment and Prognosis

Voices
Michael McNeil

Michael McNeil: One More Run, One Bigger Purpose

Teresa Amaral: Celebrating Wiebke Solass as ESMO’s 2026 Digital and Computational Pathology Fellow

Ana Dolcan: Rethinking How We Generate Evidence in Rare Cancers

Oliver Bogler: The Real Problem With Mid-Career Faculty Life

20 Years of Progress in Radiotherapy Through Mirjam’s Story - ESTRO

Gilberto Lopes: Can’t Imagine a Better Place for WCLC26 Than COEX and Seoul

Dean Crowe: Governor Brian Kemp Proclaims September as Childhood Cancer Awareness Month in Georgia

FDA Approvals
Ziihera

FDA Approves Ziihera With and Without Tislelizumab Plus Chemotherapy for First-Line HER2-Positive Gastroesophageal Adenocarcinoma

FDA Approves OncoSil Device for Distal Cholangiocarcinoma

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

OncoDaily 100
100 Influential Women in Oncology

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential People in Oncology 2026 – Nominations are Open!

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

Celebrities and Cancer

OncoCalendar

2026 Binaytara Northwest Women’s Cancer Conference

Binaytara

12 Sep
Women’s Cancer Conference

Rare Cancers Conference 2026: Advances in Diagnosis, Genomics, and Targeted Therapies

Binaytara

14 Nov
Rare Cancers Conference

The Future We Choose Together: Turning Global Evidence into Local Action

City Cancer Challenge

08 Sep
Global Evidence

ESMO Deep Dive: Are We Defeating Cervical Cancer?

European Society For Medical Oncology (ESMO)

18 Nov
ESMO Deep Dive

ESMO Preceptorship on Prostate Cancer 2027

European Society For Medical Oncology (ESMO)

13 Jan
Preceptorship on Prostate Cancer

Immune-oncology
RATIONALE-306: Tislelizumab Plus Chemotherapy Shows Sustained 3-Year Survival Benefit in Advanced ESCC

RATIONALE-306: Tislelizumab Plus Chemotherapy Shows Sustained 3-Year Survival Benefit in Advanced ESCC

Etentamig and the Next Wave of Immune Engagers in Multiple Myeloma

Dana-Farber Study Links CDK2 Activity With Response to Immune Checkpoint Blockade

Talquetamab in R/R Multiple Myeloma: Real-World Analysis From the IMWG Immunotherapy Registry

What Happens If CAR T-Cell Therapy Fails? Relapse, Refractory Disease, and Next Treatment Options

Anti-CD7 CAR T-Cell Therapy Shows Promising CNS Activity in Relapsed or Refractory T-ALL/LBL

ctDNA and MRD in NSCLC: Emerging Clinical Applications in the Immunotherapy Era

Gastrointestinal-Oncology
Esophageal Adenocarcinoma Biomarkers: HER2, PD-L1, MSI, CLDN18.2 and Emerging Targets

Esophageal Adenocarcinoma Biomarkers: HER2, PD-L1, MSI, CLDN18.2 and Emerging Targets

Esophageal Squamous Cell Carcinoma Biomarkers: PD-L1, Molecular Features and Emerging Targets

Ziihera Plus Chemotherapy Improves Overall Survival in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma

Phase 2 NEST Trial: Neoadjuvant BOT/BAL in Localized Colon Cancer

FDA Approves Daraxonrasib: First-in-Class RAS Inhibitor for Metastatic Pancreatic Cancer

SKYSCRAPER-07: Atezolizumab ± Tiragolumab After dCRT in Unresectable ESCC

TALENTOP: Liver Resection After Atezolizumab and Bevacizumab in Locally Advanced HCC

Breast-Oncology
Camizestrant

Camizestrant and ctDNA-Guided Treatment Switching: A New Paradigm in ESR1-Mutant Advanced Breast Cancer

FDA Grants Accelerated Approval to Camizestrant for ESR1-Mutated Advanced Breast Cancer

Stage I TNBC Is Not One Risk Group: Can Immune Biology Identify Patients Who Need Less Treatment?

When Bone-Only HR+/HER2− Breast Cancer Turns Visceral: What PR Expression May Tell Us in the CDK4/6 Era

Enhertu Plus Pertuzumab Approved in the EU for First-Line HER2-Positive Metastatic Breast Cancer: A New Benchmark After More Than a Decade

Trastuzumab deruxtecan Plus Pertuzumab Approved in EU for First-Line HER2-Positive Metastatic Breast Cancer

Iza-Bren Reaches the Phase III PFS Endpoint in HR+/HER2− Advanced Breast Cancer: Why PANKU-Breast01 Matters

Lung-Oncology
Pulmonary Nodules

Pulmonary Nodules in 2026: A Risk-Based Approach to Surveillance, Biopsy, and Definitive Treatment

Exercise in Lung Cancer Care: From Supportive Evidence to Global Implementation With IREX-Lung

Daraxonrasib Opens a Broader RAS-Targeting Strategy in Previously Treated NSCLC

SANOVO: Osimertinib Plus Savolitinib Moves MET-Directed Therapy Into First-Line EGFR-Mutated NSCLC

XPO1 Inhibition May Reprogram Immune Resistance in SCLC: The TRIM21–IRF3–TNFSF15–TREM2 Axis

AstraZeneca Completes Zegfrovy Deal for EGFR Exon 20 Insertion NSCLC

Adjuvant Crizotinib Fails in Resected ALK-Positive NSCLC: What E4512 Tells Us About Targeted Therapy in Early Disease

OncoDaily TV
pablo allard

Childhood Cancer Survivor Who Changed the Law: Pablo Allard’s Advocacy Journey

Cancer Care

Personalizing Colorectal Cancer Care with ctDNA? Dr. Robert Lentz

Priti Patnaik, Independent journalism

Independent journalism in global health: Priti Patnaik

Treatment Paradigms, Karine Tawagi

Evolving Treatment Paradigms in Muscle-Invasive Bladder Cancer

Cancer in Women

Cancer in Women As a Global Health and Economic Issue: Dr. Maira Caleffi

oncoffee, palliative

ONCOFFEE: Colorectal Cancer, Palliative Care, and the Human Side of Oncology: Santiago Fontes

Empowering Oncologists

Empowering Oncologists: How Policy impacts Medicine?

WHO

Mission is possible: WHO said 2030 – Rwanda said 2027: Dr. Sabin Nsanzimana

Current Landscape

The Current Landscape and Future of CAR-T in Aggressive B-Cell Lymphoma

Experts by Experience

Experts by Experience with Carmen Monge

Fighting Cervical Cancer

From Engineering to Fighting Cervical Cancer

Dr. Beatrice Addai Wiafe

Fighting Cancer With Peace And Love: Dr. Beatrice Addai Wiafe

Not To Miss
Gevorg Tamamyan

OncoDaily Editor-in-Chief Gevorg Tamamyan Awarded 2026 Global Health Catalyst Distinguished Leader Award

Highlights From LeukO 2026: Global Virtual Congress on Leukemias, Day 2

FDA Grants Accelerated Approval to Camizestrant for ESR1-Mutated Advanced Breast Cancer

TG4050 Neoantigen Vaccine Shows 100% Three-Year Disease-Free Survival in Phase 1 Head and Neck Cancer Trial

Highlights From LeukO 2026: Global Virtual Congress on Leukemias, Day 1

Etentamig Improves Response Rate and PFS in Phase 3 CERVINO Multiple Myeloma Trial

HUTCHMED and GSK Sign Up to $1.295B Licensing Deal for KRAS-EGFR Cancer Therapy HMPL-A830

OncoGrants
Kidney Cancer

CDMRP Kidney Cancer Academy Early-Career Scholar Award 2026

Early-Career Investigator Award

CDMRP Ovarian Cancer Academy Early-Career Investigator Award 2026

AACR–QuadW

AACR–QuadW Foundation Sarcoma Research Fellowship 2027

Osteosarcoma

Osteosarcoma Institute Research Grants 2026–2027

Surgical Oncology

ESSO Educational Grants for Surgical Oncology 2026

Medical Oncology Fellowship

Melanoma Institute Australia Immuno-Oncology / Medical Oncology Fellowship 2028

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Filipe Coutinho

Filipe Coutinho

Oncologists Location Santo Tirso, Portugal
Garik Sagoyan

Garik Sagoyan

Oncologists Location , Portugal
Sarfraz Ahmad

Sarfraz Ahmad

Oncologists Location Orlando, USA
Maite Gorostegui Obanos

Maite Gorostegui Obanos

Oncologists Location Barcelona, Spain
Rony Dev

Rony Dev

Oncologists Location Houston, USA
Giuseppe Caruso

Giuseppe Caruso

Oncologists Location Milan, Italy
Roshan Daniel

Roshan Daniel

Oncologists Location Thiruvananthapuram, India
Shebli Atrash

Shebli Atrash

Oncologists Location Charlotte, USA

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
Jasmin Hundal

Jasmin Hundal: New Study Reveals Breast Cancer Disparities Among South Asian American Women

Kefah Mokbel

Kefah Mokbel: ctDNA Identifies Patients at Risk of Breast Cancer Relapse

Alberto Puccini, Humanitas University

Alberto Puccini: Long Non-Coding RNAs Open New Directions in Colorectal Cancer

Wen Jiang

Wen Jiang: Translational Challenges and Opportunities in mRNA Cancer Vaccines

Victor Moreno

Victor Moreno: Rethinking What Phase 1 Means in Modern Oncology Trials

Rik Bryan

Rik Bryan: New Data Highlight the Potential of the GALEAS Bladder Test

OncoDaily Medical Journal

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

Oncology Nursing

10.69690/ODMJ-001-0826-7778

Real-World Patterns of Immune-Related Toxicity in Gastrointestinal Cancer Patients Treated with Immunotherapy: A service evaluation
Original Research

Oncology Nursing

10.69690/ODMJ-002-0826-7795

Late presentation in cancer care: Implications for treatment and survival: A Narrative Review
Reviews

GI Oncology

10.69690/ODMJ-018-0826-7959

From Plate to Polyps: Dietary N-Nitrosamines and Biomarkers of DNA Damage
Abstracts

Head and Neck Cancer

10.69690/ODMJ-018-0826-7933

A Service Review of PD-L1 Biomarker Use in the Head and Neck Cancer Service
Abstracts

Radiation Oncology

10.69690/ODMJ-018-0826-7920

Short-Course Palliative Radiotherapy for Tumour-Related Bleeding in End-of-Life Care: A Focused Literature Review
Abstracts

Pediatric Oncology

10.69690/ODMJ-018-0826-7952

FLASH radiotherapy: A Potential Way to Protect the Developing Brain in Pediatric Oncology
Abstracts

GI Oncology

10.69690/ODMJ-018-0826-7947

Real World Clinical Insights in Combination of Trifluridine-Tipiracil with Bevacizumab for Metastatic Colorectal Cancer
Abstracts